Tibet Rhodiola Pharmaceutical Holding Co. Announced earnings results for the nine months ended September 30, 2020. For the nine months, the company announced sales was CNY 989.591 million compared to CNY 931.294 million a year ago. Operating income was CNY 366.734 million compared to CNY 269.523 million a year ago. Net income was CNY 324.450 million compared to CNY 239.053 million a year ago. Basic earnings per share from continuing operations was CNY 1.5 compared to CNY 1.35 a year ago.